Literature DB >> 27893641

Routine surveillance cholangiography after percutaneous cholecystostomy delays drain removal and cholecystectomy.

Tyler J Loftus1, Scott C Brakenridge, Frederick A Moore, Camille G Dessaigne, George A Sarosi, William J Zingarelli, Janeen R Jordan, Chasen A Croft, R Stephen Smith, Philip A Efron, Alicia M Mohr.   

Abstract

INTRODUCTION: Percutaneous cholecystostomy (PC) is often performed for patients with acute cholecystitis who are at high risk for operative morbidity and mortality. However, the necessity for routine cholangiography after PC remains unclear. We hypothesized that routine surveillance cholangiography (RSC) after PC would provide no benefit compared to on-demand cholangiography (ODC) triggered by signs or symptoms of biliary pathology.
METHODS: We performed a 3-year retrospective cohort analysis of patients managed with PC for acute cholecystitis at two tertiary care hospitals. Patients who had routine surveillance cholangiography (RSC, n = 43) were compared to patients who had on-demand cholangiography (ODC, n = 41) triggered by recurrent biliary disease.
RESULTS: RSC and ODC groups were similar by severity of acute cholecystitis, presence of gallstones, systemic inflammatory response syndrome (SIRS) criteria at the time of PC, SIRS criteria 72 hours after PC, and hospital length of stay. Two patients in the ODC group developed clinical indications for cholangiography. All 44 RSC patients had cholangiography, and 67 total cholangiograms were performed in this group. Surveillance cholangiography identified six patients (14%) with cystic duct filling defect and seven patients (16%) with a common bile duct filling defect, all of whom were asymptomatic. Fifteen patients (35%) in the RSC group had 32 ERCP procedures; five patients (12%) in the ODC group had 7 ERCPs (p = 0.021). The ODC group had fewer days to drain removal (35 vs. 61, p < 0.001) and days to cholecystectomy (39 vs. 81, p = 0.005). Rates of recurrent cholecystitis, cholangitis, gallstone pancreatitis, drain removal, and cholecystectomy were similar between groups.
CONCLUSION: RSC after PC for acute cholecystitis identified biliary pathology in asymptomatic patients and propagated further testing, but did not provide clinical benefit. ODC was associated with earlier drain removal, earlier cholecystectomy, and decreased resource utilization. LEVEL OF EVIDENCE: Prognostic study, level III; therapeutic study, level IV.

Entities:  

Mesh:

Year:  2017        PMID: 27893641      PMCID: PMC5250547          DOI: 10.1097/TA.0000000000001315

Source DB:  PubMed          Journal:  J Trauma Acute Care Surg        ISSN: 2163-0755            Impact factor:   3.313


  25 in total

1.  A prospective study of common bile duct calculi in patients undergoing laparoscopic cholecystectomy: natural history of choledocholithiasis revisited.

Authors:  Chris Collins; Donal Maguire; Adrian Ireland; Edward Fitzgerald; Gerald C O'Sullivan
Journal:  Ann Surg       Date:  2004-01       Impact factor: 12.969

Review 2.  Meta-analysis of randomized controlled trials on the safety and effectiveness of early versus delayed laparoscopic cholecystectomy for acute cholecystitis.

Authors:  K Gurusamy; K Samraj; C Gluud; E Wilson; B R Davidson
Journal:  Br J Surg       Date:  2010-02       Impact factor: 6.939

3.  A comparison of intraoperative ultrasound versus cholangiography in the evaluation of the common bile duct during laparoscopic cholecystectomy.

Authors:  J A Barteau; D Castro; M E Arregui; C Tetik
Journal:  Surg Endosc       Date:  1995-05       Impact factor: 4.584

4.  Percutaneous cholecystostomy is an effective definitive treatment option for acute acalculous cholecystitis.

Authors:  J Kirkegård; T Horn; S D Christensen; L P Larsen; A R Knudsen; F V Mortensen
Journal:  Scand J Surg       Date:  2015-01-07       Impact factor: 2.360

5.  Cost-effective treatment of patients with symptomatic cholelithiasis and possible common bile duct stones.

Authors:  Lisa M Brown; Stanley J Rogers; John P Cello; Karen J Brasel; John M Inadomi
Journal:  J Am Coll Surg       Date:  2011-03-27       Impact factor: 6.113

6.  Outcome after percutaneous cholecystostomy for acute cholecystitis: a single-center experience.

Authors:  Yun-Cheng Hsieh; Chun-Ku Chen; Chien-Wei Su; Che-Chang Chan; Teh-Ia Huo; Chia-Jen Liu; Wen-Liang Fang; Kuei-Chuan Lee; Han-Chieh Lin
Journal:  J Gastrointest Surg       Date:  2012-07-25       Impact factor: 3.452

7.  Management of acute cholecystitis in critically ill patients: contemporary role for cholecystostomy and subsequent cholecystectomy.

Authors:  Bryan C Morse; J Brandon Smith; Richard B Lawdahl; Richard H Roettger
Journal:  Am Surg       Date:  2010-07       Impact factor: 0.688

8.  Percutaneous cholecystostomy for acute cholecystitis in patients with high comorbidity and re-evaluation of treatment efficacy.

Authors:  Ye Rim Chang; Young-Joon Ahn; Jin-Young Jang; Mee Joo Kang; Wooil Kwon; Woo Hyun Jung; Sun-Whe Kim
Journal:  Surgery       Date:  2014-01-11       Impact factor: 3.982

9.  Percutaneous cholecystostomy in acute acalculous cholecystitis.

Authors:  H Berger; E Pratschke; H Arbogast; A Stäbler
Journal:  Hepatogastroenterology       Date:  1989-10

10.  Percutaneous cholecystostomy in critically ill patients with acute cholecystitis: complications and late outcome.

Authors:  E Atar; G N Bachar; S Berlin; C Neiman; E Bleich-Belenky; S Litvin; M Knihznik; A Belenky; E Ram
Journal:  Clin Radiol       Date:  2014-03-01       Impact factor: 2.350

View more
  2 in total

1.  Outcomes Following Percutaneous Cholecystostomy Tube Placement for Acalculous Versus Calculous Cholecystitis.

Authors:  Stephanie Y Chen; Raymond Huang; Joseph Kallini; Ashley M Wachsman; Richard J Van Allan; Daniel R Margulies; Edward H Phillips; Galinos Barmparas
Journal:  World J Surg       Date:  2022-04-16       Impact factor: 3.282

Review 2.  Management of Patients With Acute Cholecystitis After Percutaneous Cholecystostomy: From the Acute Stage to Definitive Surgical Treatment.

Authors:  Yu-Liang Hung; Chang-Mu Sung; Chih-Yuan Fu; Chien-Hung Liao; Shang-Yu Wang; Jun-Te Hsu; Ta-Sen Yeh; Chun-Nan Yeh; Yi-Yin Jan
Journal:  Front Surg       Date:  2021-04-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.